These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27015909)

  • 61. Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients.
    Handelsman L; Limpitlaw L; Williams D; Schmeidler J; Paris P; Stimmel B
    Drug Alcohol Depend; 1995 Oct; 39(3):173-80. PubMed ID: 8556965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review.
    F Martins ML; Wilthagen EA; Oviedo-Joekes E; Beijnen JH; de Grave N; Uchtenhagen A; Beck T; Van den Brink W; Schinkel AH
    Drug Alcohol Depend; 2021 Oct; 227():108984. PubMed ID: 34482044
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials.
    Castells X; Casas M; Vidal X; Bosch R; Roncero C; Ramos-Quiroga JA; Capellà D
    Addiction; 2007 Dec; 102(12):1871-87. PubMed ID: 18031423
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment outcomes of stimulant misusers: one year follow-up results from the national treatment outcome research study (NTORS).
    Gossop M; Marsden J; Stewart D
    Addict Behav; 2000; 25(4):509-22. PubMed ID: 10972443
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.
    Schwartz RP; Kelly SM; O'Grady KE; Gandhi D; Jaffe JH
    Addiction; 2012 May; 107(5):943-52. PubMed ID: 22029398
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.
    LaRowe SD; Mardikian P; Malcolm R; Myrick H; Kalivas P; McFarland K; Saladin M; McRae A; Brady K
    Am J Addict; 2006; 15(1):105-10. PubMed ID: 16449100
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.
    Galloway GP; Buscemi R; Coyle JR; Flower K; Siegrist JD; Fiske LA; Baggott MJ; Li L; Polcin D; Chen CY; Mendelson J
    Clin Pharmacol Ther; 2011 Feb; 89(2):276-82. PubMed ID: 21178989
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.
    Lintzeris N; Strang J; Metrebian N; Byford S; Hallam C; Lee S; Zador D;
    Harm Reduct J; 2006 Sep; 3():28. PubMed ID: 17002810
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
    Palis H; Marchand K; Guh D; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2017 May; 12(1):25. PubMed ID: 28526048
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Replacement medication for cocaine dependence: methylphenidate.
    Grabowski J; Roache JD; Schmitz JM; Rhoades H; Creson D; Korszun A
    J Clin Psychopharmacol; 1997 Dec; 17(6):485-8. PubMed ID: 9408812
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users.
    Levin FR; Mariani JJ; Pavlicova M; Choi CJ; Mahony AL; Brooks DJ; Bisaga A; Dakwar E; Carpenter KM; Naqvi N; Nunes EV; Kampman K
    Drug Alcohol Depend; 2020 Jan; 206():107700. PubMed ID: 31753736
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Decreasing intravenous cocaine use in opiate users treated with prescribed heroin.
    Blättler R; Dobler-Mikola A; Steffen T; Uchtenhagen A
    Soz Praventivmed; 2002; 47(1):24-32. PubMed ID: 12050926
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of religiosity and spirituality on drug treatment outcomes.
    Conner BT; Anglin MD; Annon J; Longshore D
    J Behav Health Serv Res; 2009 Apr; 36(2):189-98. PubMed ID: 18770043
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin.
    Ghitza UE; Epstein DH; Schmittner J; Vahabzadeh M; Lin JL; Preston KL
    J Consult Clin Psychol; 2007 Oct; 75(5):765-74. PubMed ID: 17907858
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.
    Oviedo-Joekes E; Palis H; Guh D; Marchand K; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT
    Drug Alcohol Rev; 2018 Jan; 37(1):137-146. PubMed ID: 28593748
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study.
    Hassan HE; Kelly D; Honick M; Shukla S; Ibrahim A; Gorelick DA; Glassman M; McMahon RP; Wehring HJ; Kearns AM; Feldman S; Yu M; Bauer K; Wang JB
    J Clin Pharmacol; 2017 Feb; 57(2):151-160. PubMed ID: 27363313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adverse events among patients in a behavioral treatment trial for heroin and cocaine dependence: effects of age, race, and gender.
    Schroeder JR; Schmittner JP; Epstein DH; Preston KL
    Drug Alcohol Depend; 2005 Oct; 80(1):45-51. PubMed ID: 16157230
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Employment and paid work among participants in a randomized controlled trial comparing diacetylmorphine and hydromorphone.
    Nikoo M; Vogel M; Choi F; Song MJ; Burghardt J; Zafari Z; Tabi K; Frank A; Barbic S; Schütz C; Jang K; Krausz M
    Int J Drug Policy; 2018 Jul; 57():18-24. PubMed ID: 29655955
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acupuncture for crack-cocaine detoxification: experimental evaluation of efficacy.
    Lipton DS; Brewington V; Smith M
    J Subst Abuse Treat; 1994; 11(3):205-15. PubMed ID: 8072048
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study.
    Meneses-Gaya C; Crippa JA; Hallak JE; Miguel AQ; Laranjeira R; Bressan RA; Zuardi AW; Lacerda AL
    Braz J Psychiatry; 2021; 43(5):467-476. PubMed ID: 33146345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.